Effects of nonesterified fatty acids on the synthesis and assembly of very low density lipoprotein in bovine hepatocytes in vitro. 2014

Lei Liu, and Xinwei Li, and Yu Li, and Yuan Guan, and Yuxiang Song, and Liheng Yin, and Hui Chen, and Liancheng Lei, and Juxiong Liu, and Xiaobing Li, and Zhe Wang, and Xiaoyu Yang, and Guowen Liu
Key Laboratory of Zoonosis, Ministry of Education, College of Veterinary Medicine, Jilin University, 5333 Xi'an Road, Changchun, Jilin, 130062, China.

High serum concentrations of nonesterified fatty acids (NEFA), which may affect the synthesis and assembly of very low density lipoproteins (VLDL), are associated with fatty liver during the early lactation period. Therefore, the objective of this study was to investigate the effects of NEFA on the synthesis and assembly of VLDL in bovine hepatocytes. Bovine hepatocytes were cultured and treated with different concentrations of NEFA. The mRNA expression of apolipoprotein B100 (ApoB100) and apolipoprotein E (ApoE) was significantly lower in the NEFA treatment groups than in the control group (0mM NEFA). The abundance of mRNA from microsomal triglyceride transfer protein (MTP) and the low density lipoprotein receptor (LDLR) was significantly lower in the medium- and high-dose NEFA treatment groups. The protein expression of ApoB100, ApoE, MTP, and LDLR was found to be significantly and dose-dependently decreased in groups of NEFA-treated hepatocytes. The VLDL content was also significantly decreased in the NEFA-treated hepatocytes. Large amounts of triglycerides accumulated in the hepatocytes. These results indicate that NEFA significantly inhibits the expression of ApoB100, ApoE, MTP, and LDLR, thereby decreasing the synthesis and assembly of VLDL and inducing TG accumulation in bovine hepatocytes.

UI MeSH Term Description Entries
D008079 Lipoproteins, VLDL A class of lipoproteins of very light (0.93-1.006 g/ml) large size (30-80 nm) particles with a core composed mainly of TRIGLYCERIDES and a surface monolayer of PHOSPHOLIPIDS and CHOLESTEROL into which are imbedded the apolipoproteins B, E, and C. VLDL facilitates the transport of endogenously made triglycerides to extrahepatic tissues. As triglycerides and Apo C are removed, VLDL is converted to INTERMEDIATE-DENSITY LIPOPROTEINS, then to LOW-DENSITY LIPOPROTEINS from which cholesterol is delivered to the extrahepatic tissues. Pre-beta-Lipoprotein,Prebeta-Lipoprotein,Prebeta-Lipoproteins,Very Low Density Lipoprotein,Very-Low-Density Lipoprotein,Very-Low-Density Lipoproteins,Lipoprotein VLDL II,Lipoproteins, VLDL I,Lipoproteins, VLDL III,Lipoproteins, VLDL1,Lipoproteins, VLDL2,Lipoproteins, VLDL3,Pre-beta-Lipoproteins,Lipoprotein, Very-Low-Density,Lipoproteins, Very-Low-Density,Pre beta Lipoprotein,Pre beta Lipoproteins,Prebeta Lipoprotein,Prebeta Lipoproteins,VLDL Lipoproteins,VLDL1 Lipoproteins,VLDL2 Lipoproteins,VLDL3 Lipoproteins,Very Low Density Lipoproteins
D011973 Receptors, LDL Receptors on the plasma membrane of nonhepatic cells that specifically bind LDL. The receptors are localized in specialized regions called coated pits. Hypercholesteremia is caused by an allelic genetic defect of three types: 1, receptors do not bind to LDL; 2, there is reduced binding of LDL; and 3, there is normal binding but no internalization of LDL. In consequence, entry of cholesterol esters into the cell is impaired and the intracellular feedback by cholesterol on 3-hydroxy-3-methylglutaryl CoA reductase is lacking. LDL Receptors,Lipoprotein LDL Receptors,Receptors, Low Density Lipoprotein,LDL Receptor,LDL Receptors, Lipoprotein,Low Density Lipoprotein Receptor,Low Density Lipoprotein Receptors,Receptors, Lipoprotein, LDL,Receptor, LDL,Receptors, Lipoprotein LDL
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D002417 Cattle Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor. Beef Cow,Bos grunniens,Bos indicus,Bos indicus Cattle,Bos taurus,Cow,Cow, Domestic,Dairy Cow,Holstein Cow,Indicine Cattle,Taurine Cattle,Taurus Cattle,Yak,Zebu,Beef Cows,Bos indicus Cattles,Cattle, Bos indicus,Cattle, Indicine,Cattle, Taurine,Cattle, Taurus,Cattles, Bos indicus,Cattles, Indicine,Cattles, Taurine,Cattles, Taurus,Cow, Beef,Cow, Dairy,Cow, Holstein,Cows,Dairy Cows,Domestic Cow,Domestic Cows,Indicine Cattles,Taurine Cattles,Taurus Cattles,Yaks,Zebus
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005230 Fatty Acids, Nonesterified FATTY ACIDS found in the plasma that are complexed with SERUM ALBUMIN for transport. These fatty acids are not in glycerol ester form. Fatty Acids, Free,Free Fatty Acid,Free Fatty Acids,NEFA,Acid, Free Fatty,Acids, Free Fatty,Acids, Nonesterified Fatty,Fatty Acid, Free,Nonesterified Fatty Acids
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001057 Apolipoproteins E A class of protein components which can be found in several lipoproteins including HIGH-DENSITY LIPOPROTEINS; VERY-LOW-DENSITY LIPOPROTEINS; and CHYLOMICRONS. Synthesized in most organs, Apo E is important in the global transport of lipids and cholesterol throughout the body. Apo E is also a ligand for LDL receptors (RECEPTORS, LDL) that mediates the binding, internalization, and catabolism of lipoprotein particles in cells. There are several allelic isoforms (such as E2, E3, and E4). Deficiency or defects in Apo E are causes of HYPERLIPOPROTEINEMIA TYPE III. Apo-E,Apo E,Apo E Isoproteins,ApoE,Apolipoprotein E Isoproteins,Apoprotein (E),Apoproteins E,Isoproteins, Apo E,Isoproteins, Apolipoprotein E
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D014280 Triglycerides An ester formed from GLYCEROL and three fatty acid groups. Triacylglycerol,Triacylglycerols,Triglyceride

Related Publications

Lei Liu, and Xinwei Li, and Yu Li, and Yuan Guan, and Yuxiang Song, and Liheng Yin, and Hui Chen, and Liancheng Lei, and Juxiong Liu, and Xiaobing Li, and Zhe Wang, and Xiaoyu Yang, and Guowen Liu
June 2021, Veterinary sciences,
Lei Liu, and Xinwei Li, and Yu Li, and Yuan Guan, and Yuxiang Song, and Liheng Yin, and Hui Chen, and Liancheng Lei, and Juxiong Liu, and Xiaobing Li, and Zhe Wang, and Xiaoyu Yang, and Guowen Liu
May 2006, Future cardiology,
Lei Liu, and Xinwei Li, and Yu Li, and Yuan Guan, and Yuxiang Song, and Liheng Yin, and Hui Chen, and Liancheng Lei, and Juxiong Liu, and Xiaobing Li, and Zhe Wang, and Xiaoyu Yang, and Guowen Liu
November 1997, Biochemical Society transactions,
Lei Liu, and Xinwei Li, and Yu Li, and Yuan Guan, and Yuxiang Song, and Liheng Yin, and Hui Chen, and Liancheng Lei, and Juxiong Liu, and Xiaobing Li, and Zhe Wang, and Xiaoyu Yang, and Guowen Liu
July 2002, American journal of veterinary research,
Lei Liu, and Xinwei Li, and Yu Li, and Yuan Guan, and Yuxiang Song, and Liheng Yin, and Hui Chen, and Liancheng Lei, and Juxiong Liu, and Xiaobing Li, and Zhe Wang, and Xiaoyu Yang, and Guowen Liu
January 2002, Journal of the Royal Society of Medicine,
Lei Liu, and Xinwei Li, and Yu Li, and Yuan Guan, and Yuxiang Song, and Liheng Yin, and Hui Chen, and Liancheng Lei, and Juxiong Liu, and Xiaobing Li, and Zhe Wang, and Xiaoyu Yang, and Guowen Liu
November 1992, The Biochemical journal,
Lei Liu, and Xinwei Li, and Yu Li, and Yuan Guan, and Yuxiang Song, and Liheng Yin, and Hui Chen, and Liancheng Lei, and Juxiong Liu, and Xiaobing Li, and Zhe Wang, and Xiaoyu Yang, and Guowen Liu
January 2006, Journal of dairy science,
Lei Liu, and Xinwei Li, and Yu Li, and Yuan Guan, and Yuxiang Song, and Liheng Yin, and Hui Chen, and Liancheng Lei, and Juxiong Liu, and Xiaobing Li, and Zhe Wang, and Xiaoyu Yang, and Guowen Liu
September 1982, The Journal of biological chemistry,
Lei Liu, and Xinwei Li, and Yu Li, and Yuan Guan, and Yuxiang Song, and Liheng Yin, and Hui Chen, and Liancheng Lei, and Juxiong Liu, and Xiaobing Li, and Zhe Wang, and Xiaoyu Yang, and Guowen Liu
March 1979, The Journal of biological chemistry,
Lei Liu, and Xinwei Li, and Yu Li, and Yuan Guan, and Yuxiang Song, and Liheng Yin, and Hui Chen, and Liancheng Lei, and Juxiong Liu, and Xiaobing Li, and Zhe Wang, and Xiaoyu Yang, and Guowen Liu
December 1972, The Japanese journal of dermatology. Ser. B,
Copied contents to your clipboard!